Clinical trial Recruiting at 1 site Interventional Ages 18 and up

At-home electrical stimulation for bowel management in spinal cord injury

Official title: At-Home Feasibility Trial of Genital Nerve Stimulation to Modulate Neurogenic Bowel Dysfunction in Individuals Living With Spinal Cord Injury

Run by MetroHealth Medical Center · NCT06836739 · Data updated 2026-11-12

This study is testing if using a special electrical device at home can help people with spinal cord injuries have fewer bowel accidents.

More Spinal Cord Injury trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment12 (estimated)
SponsorMetroHealth Medical Center
Academic / other
Locations1 site (Cleveland, Ohio)
StatusRecruiting
StartedMarch 1, 2025
Main results expectedSeptember 30, 2027
Study endsSeptember 30, 2027
Registry record updatedNovember 3, 2026
Trial IDNCT06836739 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older with traumatic spinal cord injuries at least six months post-injury and specific neurological injury levels.

Probably not a fit

Patients currently enrolled in other electrical stimulation trials or those with certain medical devices or complications may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study tests the effectiveness of electrical stimulation applied to the skin in the pelvic area to reduce bowel accidents in individuals with spinal cord injuries. Participants will use an FDA-approved TENS device at home for 6-8 hours daily over four weeks, while researchers will compare the effects of active stimulation against a placebo. The study aims to evaluate the feasibility of this approach as an alternative bowel management option, focusing on dosage and adherence. Participants will also maintain a daily diary of their bowel symptoms and stimulation usage.

Why it matters

Potential benefit: If successful, this approach could provide a non-invasive alternative for managing bowel dysfunction in patients with spinal cord injuries.

How similar studies have gone: While the approach of using electrical stimulation for bowel management is innovative, similar studies have shown promise in related areas, suggesting potential for success.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Traumatic SCI.
2. Minimum of 6 months' post-injury.
3. Aged 18 years and older.
4. Neurological level of injury T12 or higher and AIS grade A-D, as defined by the ISNCSCI.
5. Score of 14 or higher on the ISCI BF BDS v2.1.
6. Response to genital nerve stimulation able to be elicited upon screening.
7. Able to understand and provide informed consent.

Exclusion Criteria:

1. Currently enrolled in another functional electrical stimulation (FES) research trial.
2. Females who are pregnant or planning to become pregnant in the duration of the trial (identified by self-report).
3. Presence of a cardiac pacemaker, implanted defibrillator, or other implanted functional electrical stimulation device if, upon clinical evaluation, it may have an interaction with GNS.
4. In the judgment of the PI and Co-Investigators, presence of medical complications that may interfere with the execution of the study.

Where it's running

  • MetroHealth Center for Rehabilitation Research
    Cleveland, Ohio, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.